- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1335
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High MICB expression as a biomarker for good prognosis of colorectal cancer ; volume:146 ; number:6 ; day:18 ; month:4 ; year:2020 ; pages:1405-1413 ; date:6.2020
Journal of cancer research and clinical oncology ; 146, Heft 6 (18.4.2020), 1405-1413, 6.2020
- Creator
-
Feng, Qingyang
Yu, Shanchao
Mao, Yihao
Ji, Meiling
Wei, Ye
He, Guodong
Chang, Wenju
Zhu, Dexiang
Ren, Li
Xu, Jianmin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-020-03159-0
- URN
-
urn:nbn:de:101:1-2020072221443882591703
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Feng, Qingyang
- Yu, Shanchao
- Mao, Yihao
- Ji, Meiling
- Wei, Ye
- He, Guodong
- Chang, Wenju
- Zhu, Dexiang
- Ren, Li
- Xu, Jianmin
- SpringerLink (Online service)
Other Objects (12)
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
LRIG1 expression and colorectal cancer prognosis
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
GUCA2A dysregulation as a promising biomarker for accurate diagnosis and prognosis of colorectal cancer
Cyr61 Expression is associated with prognosis in patients with colorectal cancer
Phytoestrogens and colorectal cancer prognosis
Electroanalytical Immunotool to Determine Matricellular Protein Periostin, a Stromal Biomarker of Prognosis in Colorectal Cancer
Expression of DNM3 is associated with good outcome in colorectal cancer
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
LRIG1 expression and colorectal cancer prognosis
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
GUCA2A dysregulation as a promising biomarker for accurate diagnosis and prognosis of colorectal cancer
Cyr61 Expression is associated with prognosis in patients with colorectal cancer
Phytoestrogens and colorectal cancer prognosis
Electroanalytical Immunotool to Determine Matricellular Protein Periostin, a Stromal Biomarker of Prognosis in Colorectal Cancer
Expression of DNM3 is associated with good outcome in colorectal cancer
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
LRIG1 expression and colorectal cancer prognosis
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
GUCA2A dysregulation as a promising biomarker for accurate diagnosis and prognosis of colorectal cancer
Cyr61 Expression is associated with prognosis in patients with colorectal cancer
Phytoestrogens and colorectal cancer prognosis
Electroanalytical Immunotool to Determine Matricellular Protein Periostin, a Stromal Biomarker of Prognosis in Colorectal Cancer